HRSA is evaluating drugmakers' 340B
contract pharmacy crackdowns
|
|
HRSA is
deciding whether to impose penalties on drugmakers that restrict the
availability of 340B discounts.
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment